These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34051319)

  • 41. Recent progress of 3D-printed microneedles for transdermal drug delivery.
    Yang Q; Zhong W; Xu L; Li H; Yan Q; She Y; Yang G
    Int J Pharm; 2021 Jan; 593():120106. PubMed ID: 33232756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo and in situ imaging of controlled-release dissolving silk microneedles into the skin by optical coherence tomography.
    Liu R; Zhang M; Jin C
    J Biophotonics; 2017 Jun; 10(6-7):870-877. PubMed ID: 26776883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The promising application of hydrogel microneedles in medical application.
    Wu Y; Tang Z; Ma S; Du L
    J Pharm Pharmacol; 2023 Aug; 75(8):1011-1020. PubMed ID: 37330272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymeric microneedles for the eye: An overview of advances and ocular applications for minimally invasive drug delivery.
    Mulkutkar M; Damani M; Sawarkar S
    Eur J Pharm Biopharm; 2024 Apr; 197():114209. PubMed ID: 38336234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microneedles with Controlled Bubble Sizes and Drug Distributions for Efficient Transdermal Drug Delivery.
    Wang QL; Zhu DD; Liu XB; Chen BZ; Guo XD
    Sci Rep; 2016 Dec; 6():38755. PubMed ID: 27929104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and evaluation of dissolving tofacitinib microneedles for effective management of rheumatoid arthritis.
    Jiang X; Chen P; Niu W; Fang R; Chen H; An Y; Wang W; Jiang C; Ye J
    Eur J Pharm Sci; 2023 Sep; 188():106518. PubMed ID: 37419290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs.
    Chu LY; Choi SO; Prausnitz MR
    J Pharm Sci; 2010 Oct; 99(10):4228-38. PubMed ID: 20737630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fabrication and characterization of dissolving microneedles for transdermal drug delivery of allopurinol.
    Chen J; Liu X; Liu S; He Z; Yu S; Ruan Z; Jin N
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1578-1586. PubMed ID: 35007175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transdermal Microneedles-A Materials Perspective.
    Ali R; Mehta P; Arshad MS; Kucuk I; Chang MW; Ahmad Z
    AAPS PharmSciTech; 2019 Dec; 21(1):12. PubMed ID: 31807980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marine polymeric microneedles for transdermal drug delivery.
    Moniz T; Costa Lima SA; Reis S
    Carbohydr Polym; 2021 Aug; 266():118098. PubMed ID: 34044917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles.
    Dangol M; Yang H; Li CG; Lahiji SF; Kim S; Ma Y; Jung H
    J Control Release; 2016 Feb; 223():118-125. PubMed ID: 26732554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
    Ling MH; Chen MC
    Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update on coating/manufacturing techniques of microneedles.
    Tarbox TN; Watts AB; Cui Z; Williams RO
    Drug Deliv Transl Res; 2018 Dec; 8(6):1828-1843. PubMed ID: 29288358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microneedles in Smart Drug Delivery.
    Bilal M; Mehmood S; Raza A; Hayat U; Rasheed T; Iqbal HMN
    Adv Wound Care (New Rochelle); 2021 Apr; 10(4):204-219. PubMed ID: 32320365
    [No Abstract]   [Full Text] [Related]  

  • 55. Structural characterisation and transdermal delivery studies on sugar microneedles: experimental and finite element modelling analyses.
    Loizidou EZ; Williams NA; Barrow DA; Eaton MJ; McCrory J; Evans SL; Allender CJ
    Eur J Pharm Biopharm; 2015 Jan; 89():224-31. PubMed ID: 25481031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis.
    Zheng L; Chen Y; Gu X; Li Y; Zhao H; Shao W; Ma T; Wu C; Wang Q
    J Control Release; 2024 Jan; 365():274-285. PubMed ID: 37979695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implantable powder-carrying microneedles for transdermal delivery of high-dose insulin with enhanced activity.
    Kim S; Yang H; Eum J; Ma Y; Fakhraei Lahiji S; Jung H
    Biomaterials; 2020 Feb; 232():119733. PubMed ID: 31901501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine.
    Guo T; Cheng N; Zhao J; Hou X; Zhang Y; Feng N
    Int J Pharm; 2019 Dec; 572():118741. PubMed ID: 31705974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
    McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.